Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04101682 · ClinicalTrials.gov registry record · Early Phase 1
Continuous Vs Single Shot Block After ACL
A Early Phase 1 study, sponsored by Northwell Health.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
NCT04101682: Clinical Trial Early Phase 1 study, sponsored by Northwell Health.
NCT04101682 is a Early Phase 1 study that was terminated before completion, run by Northwell Health. The registered enrollment target is 9 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04101682, a Early Phase 1 study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The investigators will be randomizing patients to either receive an adductor canal block in the operating room postoperatively as single shot of 20-30cc bupivacaine or to have a catheter inserted into the adductor canal which will be attached up to a continuous infusion pump of bupivacaine that will have a set flow rate over the next couple days. The investigators' hypothesis is that patients will have better pain control, sleep, and decreased opioid consumption with the use of a continuous infusion pump
Primary Outcome
Measured by a visual analogue scale (1-10)
Interventions
- DRUG Bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-09-25 |
| Est. Completion | 2022-05-17 |
| Phase | Early Phase 1 |
Why NCT04101682 stopped before completion
NCT04101682 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Bupivacaine is the first listed.
NCT04101682 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04101682 about?
NCT04101682 is a clinical study titled "Continuous Vs Single Shot Block After ACL". The investigators will be randomizing patients to either receive an adductor canal block in the operating room postoperatively as single shot of 20-30cc bupivacaine or to have a catheter inserted into the adductor canal which will be attached up to a continuous infusion pump of bupivacaine that will...
What is the current status of trial NCT04101682?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2020-09-25. Estimated completion is 2022-05-17.
What interventions are being tested in trial NCT04101682?
The interventions under investigation include: Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT04101682?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04101682's enrollment target sits among peer trials
9 1745th of 2000 higher than 219 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI